EXTENSIVE RESEARCH
FOR INNOVATIVE TISSUE PRODUCTS

At RegenTX, tissue research begins with comprehensive concepts that are developed by a carefully appointed team. Each project team is made up of a clinical expert and a scientific subject matter expert. Our internal teams focus on tissue research, product development, regulatory requirements, project management, and business development.

Honoring the gift of donation, the core focus of our work is on systemic research, coordinated control, and regulatory compliance. These carefully cultivated parameters enable us to create de-novo solutions that effectively support clinicians and the healing process of the recipients.

Our experts are continuously working on the development of innovative tissue products. Currently, the medical solutions of focus for RegenTX range from birth tissue and adipose tissue to dermis.

BIRTH TISSUE:
THE UNIQUENESS OF AMNIOTIC MEMBRANE

The development of human birth tissue allografts of the highest quality has always been at the forefront of RegenTX’s mission. Birth tissue has unique properties that may help to stimulate the body’s own healing. It possesses valuable biophysical and biochemical characteristics that may modulate various cell functions, which, on the other hand, may support wound healing and vascularization. Birth tissue may also act as a highly biocompatible natural scaffold, and is described in the literature as a material rich of serval types of stem cells, growth factors and cytokines.

Our expertise in human placental tissues, from amniotic membrane to umbilical cord, is rooted in a deep scientific understanding. Today, RegenTX offers a wide range of human amniotic membrane products.

ADIPOSE TISSUE:
A NATURAL OPTION TO ADVANCE PATIENT CARE

Autologous fat transfer is a popular clinical option for supporting the patient’s adipose tissues. Adipose tissue allografts have the potential to advance patient care with an easily accessible, natural option in contrast to an expensive autologous fat transfer procedure. Additionally, recent research has further characterized adipose tissue as a complex and highly active endocrine organ.

Our ongoing research program concentrates on innovating the potential of adipose tissue as a regulatory-compliant structural allograft that supports the patient’s own adipose tissues. This program has already identified several technologies critical for the safe, effective, and responsible processing of adipose tissue.

DERMAL ALLOGRAFTS:
ACCELERATING TISSUE INNOVATIONS

At RegenTX, we accelerate tissue innovations of recognized treatments, which include dermal allografts. Dermis is the first line of deeper anatomical structures. It is a commonly used allograft for protection of skin wound treatment. As dermis is a dense network of tough, elastic collagen fibers, minimal manipulation of the allograft is crucial to secure its function as a barrier.

The purpose of our dermal tissue-based allografts research program is to modernize the processing methods to produce an effective and compliant allograft. It is expected to be launched in 2024.

We look forward to telling you more about our exciting company.

If you are interested in collaborating with us, please get in touch.

contact us